- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Methylprednisolone effectively controls post operative pain in Total knee arthroplasty
Methylprednisolone could significantly decrease postoperative pain score, narcotic consumption and opioid-related adverse effects after total knee arthroplasty (TKA), reports a meta-analysis published in the International Journal of Surgery.
Methylprednisolone is a corticosteroid which is used to treat a number of different conditions, such as inflammation (swelling), severe allergies, adrenal problems, arthritis, asthma, blood or bone marrow problems, eye or vision problems, lupus, skin conditions, kidney problems, ulcerative colitis, and flare-ups of multiple sclerosis
Pain management after arthroplasties has become a serious problem. Sheng Shen and his associates performed a meta-analysis from randomized controlled trials (RCTs) to examine the efficacy and safety of methylprednisolone in the setting of postoperative pain after total knee arthroplasty.
The researchers extracted data from Medline, Embase, ScienceDirect and the Web of Science. Eligibility criteria included participants with knee osteoarthritis who prepared for TKA. The intervention groups received methylprednisolone in the management of postoperative pain. The control groups received placebo.
The primary outcomes were the visual analog scale (VAS) scores and narcotic consumption. The secondary outcomes include adverse effects (gastrointestinal events and pruritus) and postoperative complications (deep venous thrombosis, pulmonary embolism, and infection).
Read Also: Liposomal bupivacaine not beneficial for pain management after knee surgery
Key study findings:
- Patients who received methylprednisolone had significant reductions in pain score vs those who received placebo at 6 hours,12 hours and24 hours.
- Narcotic consumption was significantly lower in patients who received methylprednisolone at 6 hours, 12 hours and 24 hours.
- The risk of adverse events (nausea, vomiting, and pruritus) was significantly higher in patients receiving placebo.
- Postoperative complications were not significantly different between groups.
The study concluded that Methylprednisolone is effective, safe and significantly decreases postoperative pain score after TKA.
Knee replacement, also known as knee arthroplasty, is a surgical procedure to replace the weight-bearing surfaces of the knee joint to relieve pain and disability. It is most commonly performed for osteoarthritis, and also for other knee diseases such as rheumatoid arthritis and psoriatic arthritis.
For reference log on to https://doi.org/10.1016/j.ijsu.2018.07.009
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd